Comparison of Patients with Community-Acquired Pneumonia Who Did and Did not Receive Treatment in Accordance with the 2009 Pneumonia Guideline of Turkish Thoracic Society

被引:3
|
作者
Soylar, Oznur Kilic [1 ]
Kilinc, Oguz [1 ]
Ellidokuz, Hulya [2 ]
机构
[1] Dokuz Eylul Univ, Fac Med, Dept Chest Dis, Izmir, Turkey
[2] Dokuz Eylul Univ, Biostat Discipline, Dept Prevent Oncol, Izmir, Turkey
关键词
Community-acquired pneumonia; pneumonia treatment guideline; adherence with guideline;
D O I
10.5152/ttd.2015.4437
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OBJECTIVES: The purpose of our study was to compare community-acquired pneumonia (CAP) patients who were and were not administered treatment in accordance with the Turkish Thoracic Society (TTS) 2009 pneumonia guideline in terms of hospital stay length, treatment cost, and treatment efficacy. MATERIAL AND METHODS: Patients who were admitted to our hospital and who were diagnosed with CAP were included in the study. Demographic characteristics of the patients, symptoms at the time of diagnosis, physical examination, laboratory and radiological findings, treatments, response to treatment at follow-up, length of hospital stay, and direct cost of treatment were recorded in the TTS pneumonia database (TURCAP: TURKEY Community Acquired Pneumonia). Taking into consideration the "Turkish Thoracic Society Consensus Report on the Diagnosis and Treatment of Community-acquired pneumonia in Adults (2009)," the patients recorded in the database were evaluated in terms of conformity to the guideline. RESULTS: This present study included 156 patients diagnosed with CAP. Sixty-six patients (42.3%) were females, and 96 (57.7%) were males, and the mean age of the patients was 70.4 years. The most common symptoms on admission were cough (94.9%), expectoration of purulent sputum (77.6%), and fever (58%). Comorbid diseases were chronic obstructive pulmonary disease (COPD; 29.5%), asthma (3.2%), lung cancer (8.3%), cardiovascular diseases (32.7%), and diabetes mellitus (12.8%). It was observed that 67.3% of the patients received treatment in accordance with the guideline. No significant difference was found in terms of gender and symptoms between the groups that received and did not receive treatment in accordance with the guideline. The mean age of the patients who received treatment according to the guideline was higher than that of the patients who did not receive treatment according to the guideline; COPD was more frequent in the group of patients who received treatment according to the guideline. Pneumonia Severity Index and Confusion, Urea, Respiratory rate, Blood pressure-Age>65 scores of the patients who were treated according to the guideline was higher and treatment resulted in death in 8% of these patients. CONCLUSION: Hospital stay length, treatment cost, and treatment efficacy were similar in patients who were and were not administered treatment in accordance with the guideline.
引用
收藏
页码:64 / 67
页数:4
相关论文
共 50 条
  • [21] Validation of the 2001 American Thoracic Society criteria for severe community-acquired pneumonia
    Riley, PD
    Aronsky, D
    Dean, NC
    CRITICAL CARE MEDICINE, 2004, 32 (12) : 2398 - 2402
  • [22] Clinical Guideline Highlights for the Hospitalist: 2019 American Thoracic Society/Infectious Diseases Society of America Update on Community-Acquired Pneumonia
    Jackson, Christopher D.
    Burroughs-Ray, Desiree C.
    Summers, Nathan A.
    JOURNAL OF HOSPITAL MEDICINE, 2020, 15 (12) : 743 - 745
  • [23] British Thoracic Society adult community acquired pneumonia audit 2009/10
    Lim, Wei Shen
    Woodhead, Mark
    THORAX, 2011, 66 (06) : 548 - 549
  • [24] COMPARISON OF CEFAMANDOLE AND CEFAZOLIN FOR INITIAL TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA
    DALL, L
    CUDDY, P
    RYAN, PB
    NOHINEK, B
    RUSH, DR
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1986, 39 (06): : 946 - 951
  • [25] The comparison of patients with hospitalized health-care-associated pneumonia to community-acquired pneumonia
    Tasbakan, Mehmet Sezai
    Bacakoglu, Feza
    Basoglu, Ozen Kacmaz
    Gurgun, Alev
    Basarik, Burcu
    Tuncel, Senay Citim
    Sayiner, Abdullah
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2011, 59 (04): : 348 - 354
  • [26] Summary for Clinicians: Clinical Practice Guideline for the Diagnosis and Treatment of Community-acquired Pneumonia
    Jones, Barbara E.
    Herman, Derrick D.
    Dela Cruz, Charles S.
    Waterer, Grant W.
    Metlay, Joshua P.
    Ruminjo, Joseph K.
    Thomson, Carey C.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (02) : 133 - 138
  • [27] Admission via the emergency department in relation to mortality of adults hospitalised with community-acquired pneumonia: an analysis of the British Thoracic Society national community-acquired pneumonia audit
    Rodrigo, Chamira
    Mckeever, Tricia M.
    Woodhead, Mark
    Welham, Sally
    Lim, Wei Shen
    EMERGENCY MEDICINE JOURNAL, 2015, 32 (01) : 55 - 59
  • [28] Highlights of Clinical Practice Guideline for the Management of Community-Acquired Pneumonia 2019 Update by the American Thoracic Society and Infectious Diseases Society of America
    Wang, Hongmei
    Brong, Molly
    Pham, Shirley
    Dreucean, Diane
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2020, 28 (04) : 188 - 190
  • [29] Mortality in COPD patients with community-acquired pneumonia:: who is the third partner?
    Torres, A.
    Menendez, R.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (02) : 262 - 263
  • [30] Diagnosis and management of community-acquired pneumonia in childhood - South African thoracic society guidelines
    Zar, HJ
    Jeena, P
    Argent, A
    Gie, R
    Madhi, SA
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2005, 95 (12): : 977 - 990